Synthetic MR AB (LTS:0G79) 5-Year EBITDA Growth Rate: 0.00% (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

LTS:0G79 Synthetic MR AB LTS:0G79
63 GF Score
Price kr16.23
GF Value kr67.63
! 3 Warning Signs
View Full Analysis

What is Synthetic MR AB 5-Year EBITDA Growth Rate?

Synthetic MR AB LTS:0G79 63 5-Year EBITDA Growth Rate is 0.00% as of Jun. 2026. GuruFocus rates LTS:0G79 with a GF Score™ of 63/100 and a GF Value™ of kr67.63. The stock has 3 warning signs investors should review.

Synthetic MR AB's EBITDA per Share for the three months ended in Jun. 2026 was kr-0.03.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Synthetic MR AB was 59.70% per year. The lowest was -126.20% per year. And the median was 0.80% per year.

Synthetic MR AB  (LTS:0G79) 5-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

5-Year EBITDA Growth Rate gives an overview of the company's growth in operating profitability and is an important factor used in calculating Peter Lynch Fair Value.

Synthetic MR AB 5-Year EBITDA Growth Rate Related Terms

LTS:0G79 vs VEEV, BTSG, TEM: 5-Year EBITDA Growth Rate Comparison

For the Health Information Services subindustry, Synthetic MR AB's 5-Year EBITDA Growth Rate, along with its competitors' market caps and 5-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Synthetic MR AB 5-Year EBITDA Growth Rate vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Synthetic MR AB's 5-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Synthetic MR AB's 5-Year EBITDA Growth Rate falls into.


LTS:0G79
63GF Score
Synthetic MR AB LTS:0G79
5-Year EBITDA Growth Rate is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Synthetic MR AB 5-Year EBITDA Growth Rate Calculation

This is the 5-year average growth rate of EBITDA per Share. The growth rate is calculated with least square regression.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

What does a 5-Year EBITDA Growth Rate of 0.00% mean?
Synthetic MR AB (LTS:0G79) has a 5-Year EBITDA Growth Rate of 0.00% as of Jun. 2026. 5-Year EBITDA Growth Rate is the 5-year average growth rate of EBITDA per share. View historical data for Synthetic MR AB and its competitors.
Is Synthetic MR AB's 5-Year EBITDA Growth Rate too high?
Synthetic MR AB's current 5-Year EBITDA Growth Rate is 0.00%. Overall, Synthetic MR AB has a GF Score™ of 63/100, reflecting its overall financial health beyond just this single metric.
How does Synthetic MR AB's 5-Year EBITDA Growth Rate compare to VEEV and BTSG?
Synthetic MR AB's 5-Year EBITDA Growth Rate of 0.00% can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year EBITDA Growth Rate for a Healthcare Providers & Services company?
A good 5-Year EBITDA Growth Rate depends on the Healthcare Providers & Services industry context. However, 5-Year EBITDA Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year EBITDA Growth Rate mean?
A high 5-Year EBITDA Growth Rate can signal that a stock is expensive relative to its fundamentals. 5-Year EBITDA Growth Rate is the 5-year average growth rate of EBITDA per share. View historical data for Synthetic MR AB and its competitors. Synthetic MR AB's current 5-Year EBITDA Growth Rate is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Synthetic MR AB stock overvalued right now?
Synthetic MR AB (LTS:0G79) has a current 5-Year EBITDA Growth Rate of 0.00%. The stock's GF Value™ is kr67.63, compared to a current price of kr16.23 — trading 76% below its estimated fair value. The current 5-Year EBITDA Growth Rate is 0.00%. Synthetic MR AB's overall GF Score™ is 63/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year EBITDA Growth Rate calculated?
5-Year EBITDA Growth Rate is calculated from a company's financial statements. For Synthetic MR AB (LTS:0G79), the current 5-Year EBITDA Growth Rate is 0.00% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Synthetic MR AB (LTS:0G79) Overvalued in 2026?

Based on GuruFocus' analysis, Synthetic MR AB stock appears to be undervalued. The current stock price of kr16.23 is trading 76% below its estimated GF Value™ of kr67.63.

Key valuation signals for LTS:0G79:

  • 5-Year EBITDA Growth Rate: 0.00%
  • GF Value™: kr67.63 vs. price of kr16.23 (76% below fair value)
  • GF Score™: 63/100 with 3 warning signs

No single metric tells the full story. See the LTS:0G79 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Synthetic MR AB Business Description

Other Exchanges SYNT:Sweden9480:Germany
Address Storgatan 11, Linkoping, SWE, SE-582 23
Synthetic MR AB develops and markets software solutions that improve the efficiency of neuroimaging processes and diagnostic accuracy. SyntheticMR's SyMRI solution measures the brain's absolute tissue properties and generates multiple contrast-weighted images, performs automatic segmentation of biomarkers, and delivers quantitative data in a single rapid examination. Combinostics offers the AI-driven cNeuro product family, which helps clinicians make a difference in the lives of patients with neurological diseases. Geographically, the group operates in America, Europe, and APAC. The majority of its revenue is generated from Europe.
63GF Score

Get the complete analysis for LTS:0G79

5-Year EBITDA Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr16.23
Price
kr67.63
GF Value